Your Age-Gate Is Telling Google Your Peptide Store Doesn't Exist
Pull up Google Search Console for almost any peptide supplier site and you'll see the same pattern: forty product pages built, four indexed. The rest sit in "Crawled — currently not indexed" or, worse, "Blocked by robots.txt." The brand name ranks fine. The homepage ranks fine. Every page that actually sells something — the BPC-157 listing, the COA archive, the research-use dosing guide — is invisible. The founder assumes it's a Google penalty for "sensitive content." It's not. It's the age gate, and it's doing exactly what it was built to do: stop things from getting through.
The problem is nobody told it to stop stopping Googlebot.
The Age Gate Was Built to Protect the Business, Not to Hide It
Every compliance-first peptide site needs some form of age or affirmation gate — a checkpoint confirming the visitor is 18+, understands the product is sold for research use only, and isn't purchasing for human consumption. That requirement is real. FDA and state-level scrutiny on peptide marketing is only getting tighter, and a site that skips this step is exposed. But somewhere between "we need a legal checkpoint" and "here's the code," most builds solve the wrong problem. They gate the page, not the transaction.
Three implementations show up constantly, and each one damages indexation in a different way.
The first is a server-side redirect: any request without a verification cookie gets a 302 to /verify-age, full stop. This is the worst version. Googlebot doesn't have a cookie jar that persists the way a returning customer's browser does — it crawls stateless, page by page. So instead of ever reaching the product page, it gets redirected to the same interstitial every single time. Google indexes the redirect target, not the destination. Multiply that across forty SKUs and Google has indexed one page: your gate.
The second is a blanket Disallow: / rule scoped too broadly in robots.txt — a developer's blunt instrument for "keep bots off anything gated," which ends up blocking the entire /products/ and /coa/ directories along with it. Nobody notices because the homepage still ranks and the founder isn't checking Search Console weekly. This is the silent killer: no errors, no warnings, just months of zero indexation while competitors' pages accumulate rankings.
The third is subtler and shows up on sites that got the first two right: a full-page JavaScript modal that technically doesn't block the DOM, but ships with a noindex meta tag hardcoded into the gate template — a tag some developer added early in the build "just to be safe" and never removed once the real product templates went live. Compliance and SEO get built by two different people at two different times, and nobody audits the handoff.
Googlebot Doesn't Buy Peptides — So Why Are You Carding It?
Here's the mechanism nobody explains to founders building these sites: age-verification law and FTC guidance govern the purchase and marketing-to-humans pathway. They do not require you to block a web crawler from reading a page. Googlebot is not a 15-year-old trying to buy a research peptide. It has no age. It has no intent to purchase. Gating it provides zero legal protection and all of the SEO damage.
The confusion happens because "gate the content" and "gate the purchase" get treated as the same control point when they're not. A dispensary site, a peptide supplier, a THC brand — all of them face this exact tension, and almost all of them default to gating at page load because it feels safer. It isn't. It's just less work to implement one checkpoint instead of two. The actual legal exposure lives at checkout: someone completing a transaction, checking an affirmation box, and submitting payment through your high-risk processor. That's the moment that needs a hard, logged, timestamped verification. The blog post explaining peptide reconstitution ratios does not need the same wall.
Once you separate those two events, the fix becomes obvious: content is public and indexable. The transaction is gated. Two different systems, two different trigger points, and Google never has to fight your compliance stack to do its job.
What the Fixed Architecture Actually Looks Like
A build that gets this right looks like this. Every product page, COA archive entry, and research-use content page renders server-side with full HTML in the initial response — no redirect, no noindex, no robots block. This is table stakes for a custom peptide website design built on something like Next.js or Astro, where server-side rendering means Googlebot sees the same fully-formed page a human does on first load, not a shell waiting on client-side JavaScript to populate it.
The affirmation modal still exists — it just isn't the gatekeeper to indexation. It fires as a lightweight overlay on top of already-rendered content, dismissible, logged via a session cookie for analytics and legal record-keeping, but never blocking the crawl path and never tied to a noindex directive. Visually, a first-time human visitor sees the checkbox before they can scroll past the hero. Structurally, the page underneath was always there.
The real checkpoint — the one that matters legally — sits at add-to-cart or checkout initiation. That's where you require an explicit, timestamped, IP-logged affirmation: 18+, research-use-only acknowledgment, no intent for human consumption. That record is what protects the business if a payment processor, state AG, or FDA inquiry ever asks for proof of compliance. It's a transactional log, not a wall around your content.
COA pages get the same treatment: publicly indexable by default, with the batch-specific lookup tool (where a buyer enters a lot number to pull their specific certificate) living behind the account or order-history layer, not the general COA archive. Search engines and AI answer engines can crawl and cite your general COA methodology and testing partner info — which is exactly the kind of page that gets pulled into AI Overviews and cited as a trust signal — while the sensitive batch-to-order mapping stays access-controlled.
Robots.txt gets scoped narrowly: disallow only the actual checkout and account paths, never entire product or content directories. And someone checks Search Console monthly, not never, because a single missed redirect rule or a leftover noindex tag from a staging build can undo six months of content work in a week.
The Test: Ask Google What It Sees
Run this test on your own site right now. Open an incognito window, go to Google, and search site:yourdomain.com. If you see fewer than a third of your actual product and content pages listed, your gate is doing more legal theater than legal protection — and it's costing you the exact organic traffic that a compliant, research-focused buyer would use to find you. A buyer searching "BCP-157 COA lookup" or "research peptide reconstitution calculator" isn't going to your site directly. They're going to Google first. If Google can't see the page, it doesn't matter how airtight your affirmation language is — nobody reads it, because nobody arrives.
Compliance and visibility aren't in tension here. They only look like they are because most builds solve them with one blunt tool instead of two precise ones. The gate at the door and the gate at the register are different jobs. Build them as one, and you end up with a legally sound site that nobody can find — which, from an SEO standpoint, is functionally the same as not having a site at all.
If you're not sure which layer your current site is gating — or you've never actually checked what Googlebot sees versus what your customers see — that's a twenty-minute audit, not a rebuild. Worth a conversation before your next product launch, not after you've noticed the indexed-page count hasn't moved in six months.